• Marketsetup
  • Blog
    • By Tags
  • News
  • Documentation
    • Jugaad Data
    • Jugaad Trader

Anuh Pharma's Q1 FY26: Revenue Skyrockets, But Profitability Takes a Hit – What's Next for This API Giant?

Anuh Pharma’s latest Q1 FY26 earnings reveal a captivating paradox: soaring revenue contrasted …

Aug 22, 2025 14:10

Granules India Q1 FY26: Is This Pharma Stock's Profit Dip a Hidden Opportunity for Growth?

Granules India’s Q1 FY26 results reveal a fascinating blend of strategic expansion and …

Aug 22, 2025 13:16

Decoding Zydus Lifesciences Q1 FY26: Is This Pharma Stock Quietly Building Its Next Growth Wave?

Zydus Lifesciences’ Q1 FY26 earnings show modest growth, but beneath the surface lies a …

Aug 21, 2025 13:52

Alkem Laboratories Q1 FY26: Unpacking India Pharma's Outperformance & Strategic Bets for Future Growth

Alkem Laboratories’ Q1 FY26 results reveal a pharma giant outperforming in India while …

Aug 21, 2025 13:36

Cohance Lifesciences Q1 FY26: Is This CDMO's Growth Stalling or Accelerating?

Cohance Lifesciences’ latest earnings report presents a complex picture of growth. Discover …

Aug 21, 2025 13:14

Aarti Pharmalabs Q1 FY26: Why Headline Numbers Miss the Real Growth Story

Aarti Pharmalabs’ Q1 FY26 consolidated results appear alarming, but they hide a powerful …

Aug 21, 2025 13:06

Marksans Pharma's Q1 FY26 Shocker: Decoding the PAT Drop & Unseen Growth Drivers

Marksans Pharma’s Q1 FY'26 earnings showed a notable profit decline, but a deeper dive reveals …

Aug 21, 2025 13:04

Shilpa Medicare's Stunning 1QFY26 Profit Surge: Is a New Growth Era Here?

Unlock the secrets behind Shilpa Medicare’s surprising 1QFY26 financial results. Despite …

Aug 19, 2025 12:58

Anthem Biosciences Q1 FY26: CRDM Surges, GLP-1 Bets Fuel Future Growth – Is This Pharma Stock a Buy?

Anthem Biosciences kicked off FY26 with robust revenue and profitability, driven by its CRDM …

Aug 19, 2025 12:48

GMM Pfaudler Q1 FY26: Why the Headline PAT Number Masks a Booming Growth Story

Don’t let GMM Pfaudler’s Q1 FY26 Profit After Tax (PAT) fool you. While headline numbers …

Aug 18, 2025 14:38

Akums Q1 FY26: Why Modest Revenue Hides a Staggering Cash Infusion & Profit Surge

While Akums Drugs and Pharmaceuticals’ Q1 FY26 revenue growth appears modest, a deeper dive …

Aug 18, 2025 13:54

Innova Captab Q1 FY26 Results: Is This Pharma Stock Poised for Explosive Growth?

Innova Captab’s Q1 FY26 earnings reveal robust revenue growth, fueled by a standout …

Aug 18, 2025 13:28

GlaxoSmithKline Pharma's Q1 FY26: Flat Revenue, Explosive Profit Growth. Unpacking Their Strategic Pivot.

Discover how GSK Pharma defied expectations in Q1 FY26, turning flat revenue into a stunning profit …

Aug 18, 2025 13:06

Sequent Scientific's Q1 FY26: Double-Digit Surge in Revenue & Profits. What's Driving This Animal Health Powerhouse?

Uncover the impressive details of Sequent Scientific’s Q1 FY26 results. Learn how robust …

Aug 18, 2025 12:46

OneSource Specialty Pharma's Q1 FY '26: Is This CDMO the Next "Super Grower" Amidst Market Turmoil?

Amidst broader market corrections, OneSource Specialty Pharma’s Q1 FY ‘26 results signal …

Aug 17, 2025 13:56

Alembic Pharma Q1 FY26: Decoding Growth, Margins & Future Earnings Potential

Alembic Pharma kicked off FY26 with mixed yet encouraging Q1 results. This analysis delves into the …

Aug 17, 2025 13:48

Zim Laboratories Q1 FY26: Profit Plunge or Hidden Growth Catalyst? Unpacking the Numbers

Zim Laboratories reported a challenging Q1 FY26, with profits plummeting due to geopolitical …

Aug 17, 2025 12:46

SMS Pharma Q1 FY26: Unveiling the API Fast Grower's Path to Explosive Growth

SMS Pharmaceuticals delivered a compelling Q1 FY26, showcasing double-digit revenue and profit …

Aug 16, 2025 17:08

Gufic Biosciences Q1 FY26: Strategic Investments or Margin Meltdown? What Investors Need to Know

Gufic Biosciences’ Q1 FY26 results reveal healthy revenue growth but a noticeable dip in …

Aug 16, 2025 17:06

Eris Lifesciences Q1 FY26: Why This Pharma Stock Is Primed for Explosive Growth Amidst Market Volatility

Amidst broader market corrections, Eris Lifesciences’ Q1 FY26 results stand out. Discover how …

Aug 16, 2025 16:36

Medicamen Biotech's Staggering Q1 Loss: What Drove the Plunge and Can it Recover?

Medicamen Biotech just released its Q1 FY25 results, showing a stark swing from profit to …

Aug 16, 2025 16:26

Biocon Q1 FY26: Are These Profit Dips Actually a Masterstroke for Future Growth?

Biocon’s Q1 FY26 earnings present a nuanced picture. While headline profits dipped, this …

Aug 16, 2025 16:20

Concord Biotech's Q1FY26 Dip: Is This Biopharma Stock a Hidden Gem or a Warning Sign?

Concord Biotech’s Q1FY26 results presented a puzzling dip in revenue and EBITDA. Is this cause …

Aug 16, 2025 15:50

Caplin Point Q1 FY26 Earnings: What Analysts Are Scrutinizing & Why It Matters

Caplin Point Laboratories has released its Q1 FY26 earnings call transcript. This article delves …

Aug 15, 2025 22:06

Mangalam Drugs Q1 FY26: Sales Plunge, Inventory Soars, Profits Vanish – Unpacking the Shocking Reversal

Mangalam Drugs And Organics Limited’s Q1 FY26 results reveal a shocking financial reversal. …

Aug 15, 2025 14:36

Gland Pharma's Q1 FY26: Profit Jumps 50% & Cenexi Breaks Even – Is This The Pharma Giant's Resurgence?

Gland Pharma’s Q1 FY26 results show a powerful rebound, with profits soaring by 50% and its …

Aug 15, 2025 13:32

Medicamen Biotech Q1 FY26: Profits Plummet, But One Key Number Soars. What's Driving MBIL's Mixed Fortunes?

Medicamen Biotech’s Q1 FY26 results are in, revealing a complex financial picture. While …

Aug 15, 2025 01:22

Aurobindo Pharma Q1 FY26: Is Profit Pressure Hiding Massive Future Growth?

Aurobindo Pharma’s Q1 FY26 results present a complex picture. While profitability faced …

Aug 15, 2025 01:10

Cohance Lifesciences' USFDA Inspection: What 6 Observations Mean

Cohance Lifesciences’ Hyderabad facility completed a USFDA inspection, receiving 6 …

Aug 13, 2025 23:17

Acutaas Chemicals: Decoding the 200% Profit Leap & Strategic Bets Driving Future Growth

Amidst broader market corrections, Acutaas Chemicals’ Q1 FY26 earnings unveil a story of …

Aug 11, 2025 02:06

Senores Pharmaceuticals Q1FY26: 71% Revenue Surge & The Strategic Moves Fueling Its Super Growth

Senores Pharmaceuticals’ Q1FY26 results are turning heads with impressive growth across key …

Aug 11, 2025 01:27

Indoco Remedies Q1 FY26: Can Compliance Efforts Ignite a Full Pharma Turnaround?

Indoco Remedies’ Q1 FY26 earnings signal the initial stages of a recovery, showing sequential …

Aug 11, 2025 01:03

Lupin Partners with Zentiva for Global Biosimilar Push 🌍

Lupin has inked a strategic License and Supply Agreement with Zentiva to commercialize its …

Jul 8, 2025 22:40

Torrent Pharmaceuticals Launches Open Offer for JB Chemicals & Pharmaceuticals, Shares Decline

Torrent Pharmaceuticals Limited has announced a mandatory open offer to acquire an additional 26.00% …

Jun 30, 2025 12:31

Torrent Pharma to Acquire Majority Stake in JB Chemicals, Plans Merger; Shares React

Torrent Pharmaceuticals Limited has announced a significant move to acquire a controlling stake in …

Jun 30, 2025 12:30

Alembic Pharma Shares Surge Over 10% on USFDA Final Approval for Doxorubicin Hydrochloride Liposome Injection

Alembic Pharmaceuticals Limited (APLLTD) announced on June 29, 2025, that it has received final …

Jun 30, 2025 12:30
  • About
  • Privacy Policy
  • Contact us